Correlation Between Denali Therapeutics and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Inhibikase Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Inhibikase Therapeutics.
Diversification Opportunities for Denali Therapeutics and Inhibikase Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Denali and Inhibikase is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Inhibikase Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 1.33 times more return on investment than Inhibikase Therapeutics. However, Denali Therapeutics is 1.33 times more volatile than Inhibikase Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 2,149 in Denali Therapeutics on October 20, 2024 and sell it today you would earn a total of 44.00 from holding Denali Therapeutics or generate 2.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Denali Therapeutics |
| Inhibikase Therapeutics |
Denali Therapeutics and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Inhibikase Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Denali Therapeutics vs. Agilent Technologies | Denali Therapeutics vs. Equillium | Denali Therapeutics vs. 23Andme Holding Co | Denali Therapeutics vs. DiaMedica Therapeutics |
| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |